Zapata et al. [135] showed that transgenic mice expressing both TRAF2DN and BCL-2 in the B-cell lineage develop age-dependent B-cell leukemia and lymphoma, with similarities to human CLL (Figure 3). This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.